Banner

(S)-N-((3-(3-Fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide

CAS
154590-66-6
Catalog Number
ACM154590666
Category
Other Products
Molecular Weight
336.361343 [g/mol]
Molecular Formula
C16H21FN4O3

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
154590-66-6, SureCN1894257, CHEMBL1651124, CTK4C8340, AKOS015924505, AKOS015995158, AG-L-59507, B-2133, (S)-N-((3-(3-fluoro-4-(piperazin-1-yl)phenyl)-2-oxooxazolidin-5-yl)methyl)acetamide, Acetamide,N-[[(5S)-3-[3-fluoro-4-(1-piperazinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-
IUPAC Name
N-[[(5S)-3-(3-fluoro-4-piperazin-1-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide
InChI Key
DSRPYQXHWUDRBP-ZDUSSCGKSA-N
Exact Mass
336.16000
H-Bond Acceptor
6
H-Bond Donor
2

Upstream Synthesis Route 1

  • 174649-06-0
  • 154590-66-6

Reference: [1] Tetrahedron Letters, 2006, vol. 47, # 38, p. 6799 - 6802

Upstream Synthesis Route 2

  • 154590-65-5
  • 154590-66-6

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 18, p. 5150 - 5155

Upstream Synthesis Route 3

  • 369-34-6
  • 154590-66-6

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 19, p. 4261 - 4267
[2] Patent: WO2011/37731, 2011, A1,
[3] Bioorganic and Medicinal Chemistry, 2014, vol. 22, # 16, p. 4490 - 4498
[4] Patent: CN107033095, 2017, A,

Downstream Synthesis Route 1

  • 82419-35-0
  • 154590-66-6
  • 444335-14-2

Reference: [1]Bioorganic and Medicinal Chemistry Letters,2003,vol. 13,p. 4213 - 4216

* For details of the synthesis route, please refer to the original source to ensure accuracy.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Inquiry Basket
qrcodex
Download
Verification code
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.